GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Hippocampus

• Publication date

  2001-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/hipo.1065PMID 11732702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Excitatory amino acid neurotoxicity.

  2002cited by this paper
• Emerging principles of altered neural circuitry in schizophrenia.

  2000cited by this paper
• Differential c-Fos and caspase expression following kainic acid excitotoxicity

  2000cited by this paper
• Low‐affinity kainate receptor agonists induce insult‐dependent apoptosis and necrosis in cultured murine cortical neurons

  2000cited by this paper
• Amygdalo‐Entorhinal Inputs to the Hippocampal Formation in Relation to Schizophrenia

  2000cited by this paper
• Evidence for altered trisynaptic circuitry in schizophrenic hippocampus.

  1999cited by this paper
• Projections from the lateral, basal, and accessory basal nuclei of the amygdala to the hippocampal formation in rat

  1999cited by this paper
• Kainate receptors are involved in synaptic plasticity

  1999cited by this paper
• Kainate Receptor-Mediated Responses in the CA1 Field of Wild-Type and GluR6-Deficient Mice

  1999cited by this paper
• A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives.

  1999influential reference
• A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives.

  1998influential reference
• Distribution of glutamate decarboxylase65 immunoreactive puncta on pyramidal and nonpyramidal neurons in hippocampus of schizophrenic brain

  1998cited by this paper
• Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice

  1998influential reference
• The GluR5 subtype of kainate receptor regulates excitatory synaptic transmission in areas CA1 and CA3 of the rat hippocampus.

  1998cited by this paper
• Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons

  1997cited by this paper
• Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia.

  1997influential reference
• GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study.

  1997cited by this paper
• Uncoupling of GABA(A) and benzodiazepine receptor binding activity in the hippocampal formation of schizophrenic brain.

  1997cited by this paper
• The synaptic activation of kainate receptors

  1997cited by this paper
• Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.

  1996influential reference
• The effect of chronic haloperidol treatment on glutamate receptor subunit (GluR1, GluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain.

  1996cited by this paper
• Differences in the subregional and cellular distribution of GABAA receptor binding in the hippocampal formation of schizophrenic brain

  1996influential reference
• Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens: an animal model of schizophrenia.

  1995cited by this paper
• Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions.

  1995cited by this paper
• Kainate-induced apoptotic cell death in hippocampal neurons.

  1994influential reference
• Organization and quantitative analysis of kainate receptor subunit GluR5-7 immunoreactivity in monkey hippocampus.

  1993cited by this paper
• Oxidative stress, glutamate, and neurodegenerative disorders.

  1993cited by this paper
• Selective distribution of kainate receptor subunit immunoreactivity in monkey neocortex revealed by a monoclonal antibody that recognizes glutamate receptor subunits GluR5/6/7

  1993cited by this paper
• Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics

  1992cited by this paper
• The KA-2 subunit of excitatory amino acid receptors shows widespread expression in brain and forms ion channels with distantly related subunits.

  1992cited by this paper
• Decreased Hippocampal Expression of a Glutamate Receptor Gene in Schizophrenia

  1991cited by this paper
• Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA

  1991cited by this paper
• Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells

  1991cited by this paper
• Decreased hippocampal expression of a glutamate receptor gene in schizophrenia.

  1991cited by this paper
• Hippocampal neuron number in schizophrenia. A stereological study.

  1991cited by this paper
• Reduced neuronal size in posterior hippocampus of schizophrenic patients.

  1991cited by this paper
• Excitatory amino acid neurotoxicity and neurodegenerative disease.

  1990cited by this paper
• Systemic administration of kainic acid increases GABA levels in perfusate from the hippocampus of rats in vivo.

  1990influential reference
• Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia.

  1990cited by this paper
• Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem.

  1990cited by this paper
• Cloning of a novel glutamate receptor subunit, GluR5: expression in the nervous system during development.

  1990cited by this paper
• Frontal Cortical and Left Temporal Glutamatergic Dysfunction in Schizophrenia

  1989cited by this paper
• Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia.

  1988cited by this paper
• Neurotransmitters, receptors and neuropeptides in post‐mortem brains of chronic schizophrenic patients

  1988cited by this paper
• The Hippocampal Formation of the Primate Brain

  1987cited by this paper
• Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain

  1985cited by this paper
• Cellular and synaptic basis of kainic acid-induced hippocampal epileptiform activity.

  1983cited by this paper
• Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia.

  1983cited by this paper
• Cellular bases of hippocampal EEG in the behaving rat.

  1983cited by this paper
• A preferential loss of GABAergic, symmetric synapses in epileptic foci: a quantitative ultrastructural analysis of monkey neocortex

  1982cited by this paper
• Kainic acid produces depolarization of CA3 pyramidal cells in the vitro hippocampal slice.

  1981cited by this paper
• Acute dendrotoxic changes in the hippocampus of kainate treated rats.

  1979cited by this paper
• Neurochemical sequelae of kainate injections in corpus striatum and substantia nigra of the rat.

  1977cited by this paper
• Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea

  1976cited by this paper
• Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea.

  1976cited by this paper
• Diagnostic criteria for use in psychiatric research.

  1972cited by this paper

• 3D histological mapping of hippocampal subfields: a comparative study in patients with schizophrenia and healthy controls

  2025cites this paper
• Association of valproate use and hippocampal atrophy in idiopathic generalized epilepsy

  2025cites this paper
• Postmortem changes in brain cell structure: a review.

  2023cites this paper
• The CA2 hippocampal subfield in humans: A review

  2023cites this paper
• Machine learning-based segmentation of the rodent hippocampal CA2 area from Nissl-stained sections

  2023cites this paper
• Ultrarare Loss-of-Function Mutations in the Genes Encoding the Ionotropic Glutamate Receptors of Kainate Subtypes Associated with Schizophrenia Disrupt the Interaction with PSD95

  2022cites this paper
• Losing balance: kainate receptors and psychiatric disorders comorbidities.

  2021cites this paper
• Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants.

  2021cites this paper
• Molecular alterations in the medial temporal lobe in schizophrenia.

  2020cites this paper
• Glutamate receptors in domestication and modern human evolution.

  2019cites this paper
• Converging roles of glutamate receptors in domestication and prosociality

  2018cites this paper
• Neuroprotective effect of the ethanol extract of Artemisia capillaris on transient forebrain ischemia in mice via nicotinic cholinergic receptor.

  2018cites this paper
• Progressive Decline in Hippocampal CA1 Volume in Individuals at Ultra-High-Risk for Psychosis Who Do Not Remit: Findings from the Longitudinal Youth at Risk Study

  2017cites this paper
• University of Birmingham Progressive decline in hippocampal CA1 volume in individuals at ultra-high-risk for psychosis who do not remit

  2017cites this paper
• Prevalencia, causas y tratamiento de la depresión mayor

  2017cites this paper
• Rediscovering area CA2: unique properties and functions

  2016cites this paper
• Targeting astrocytes in bipolar disorder

  2016cites this paper
• Building models for postmortem abnormalities in hippocampus of schizophrenics.

  2015cites this paper
• Exploring mGluR5 dysregulation in schizophrenia: from gene to protein

  2015cites this paper
• The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies

  2015cites this paper
• Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.

  2015cites this paper
• The role of NMDA receptors in the pathophysiology and treatment of mood disorders.

  2014cites this paper
• Impaired hippocampus‐dependent spatial flexibility and sociability represent autism‐like phenotypes in GluK2 mice

  2014cites this paper
• The neurobiology of bipolar disorder: identifying targets for specific agents and synergies for combination treatment.

  2014cites this paper
• GPR50, a potential factor involved in psychiatric disorders interacts with Alzheimer’s disease-related protein β- secretase (BACE1)

  2014cites this paper
• Role of Lysophosphatidic Acid (LPA) in Behavioral Processes: Implications for Psychiatric Disorders

  2013cites this paper
• Kainate receptors in health and disease.

  2013cites this paper
• GRIK4/KA1 protein expression in human brain and correlation with bipolar disorder risk variant status

  2012cites this paper
• Glutamatergic synaptic dysregulation in schizophrenia: therapeutic implications.

  2012cites this paper
• Glutamatergic Synaptic Dysregulation in Schizophrenia

  2012cites this paper
• Does conventional anti-bipolar and antidepressant drug therapy reduce NMDA-mediated neuronal excitation by downregulating astrocytic GluK2 function?

  2012cites this paper
• Glutamate Receptor Abnormalities in Schizophrenia: Implications for Innovative Treatments

  2012cites this paper
• Role of lysophosphatidic acid as lipid mediator in behavior

  2011cites this paper
• Neuroimaging and neuropathological findings in bipolar disorder.

  2011cites this paper
• Effect of isolation rearing on the expression of AMPA glutamate receptors in the hippocampal formation

  2011cites this paper
• Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia.

  2011cites this paper
• Behavioral neurobiology of bipolar disorder and its treatment

  2011cites this paper
• Factoring neurotrophins into a neurite-based pathophysiological model of schizophrenia.

  2011cites this paper
• Contributions of Glutamate and GABA Systems to the Neurobiology and Treatment of Schizophrenia

  2011cites this paper
• Common proteomic changes in the hippocampus in schizophrenia and bipolar disorder and particular evidence for involvement of cornu ammonis regions 2 and 3.

  2011cites this paper
• Neurotransmitter Systems in Bipolar Disorder

  2010cites this paper
• Studies on neuronal signaling in the hippocampus related to development, pathogenesis and treatment of mood disorders

  2010cites this paper
• Are GRIK3 (T928G) gene variants in schizophrenia patients different from those in their first-degree relatives?

  2010cites this paper
• Amygdalocortical Circuitry in Schizophrenia: From Circuits to Molecules

  2010influential citation
• Ultrastructural abnormalities of astrocytes in the hippocampus in schizophrenia and duration of illness: A postortem morphometric study

  2010cites this paper
• The Neuropeptide VGF Is Reduced in Human Bipolar Postmortem Brain and Contributes to Some of the Behavioral and Molecular Effects of Lithium

  2010cites this paper
• Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.

  2010cites this paper
• Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans.

  2010cites this paper
• Hippocampal kainate receptors.

  2010cites this paper
• Functional role of kainate receptors in the rat entorhinal cortex.

  2009cites this paper
• A possible association between schizophrenia and GRIK3 polymorphisms in a multicenter sample of Scandinavian origin (SCOPE).

  2009cites this paper
• Neurobiological evidence for thalamic, hippocampal and related glutamatergic abnormalities in bipolar disorder: a review and synthesis.

  2009cites this paper
• Common Gene Variants in Schizophrenia Susceptibility with Focus on Neurodevelopment

  2009influential citation
• Lack of association of three GRIN2B polymorphisms with bipolar disorder

  2009cites this paper
• Alterations of Neurotransmitter Receptors in Schizophrenia: Evidence from Postmortem Studies

  2009cites this paper
• Candidate gene studies in psychiatric illness

  2009cites this paper
• Course and Pattern of Cingulate Pathology in Schizophrenia

  2009influential citation
• The cognitive neuroscience of memory function and dysfunction in schizophrenia.

  2008cites this paper
• Genomic imprinting in the development and evolution of psychotic spectrum conditions

  2008cites this paper
• Cognitive Neuroscience of Memory Function and ysfunction in Schizophrenia

  2008cites this paper
• The amygdala modulates neuronal activation in the hippocampus in response to spatial novelty

  2008cites this paper
• [The pathology of the hippocampus in schizophrenia].

  2007cites this paper
• Neurogenesis and neuroenhancement in the pathophysiology and treatment of bipolar disorder.

  2007cites this paper
• Chronic phencyclidine administration reduces the expression and editing of specific glutamate receptors in rat prefrontal cortex.

  2007cites this paper
• Rat modeling for GABA defects in schizophrenia.

  2006cites this paper
• Effects of genes and stress on the neurobiology of depression.

  2006cites this paper
• Rat Modeling for GABA Defects

  2006cites this paper
• Association study of polymorphisms in the GluR7, KA1 and KA2 kainate receptor genes (GRIK3, GRIK4, GRIK5) with schizophrenia.

  2006cites this paper
• Decreased numerical density of kainate receptor-positive neurons in the orbitofrontal cortex of chronic schizophrenics

  2006cites this paper
• N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels.

  2006cites this paper
• Ultrastructural alterations in hippocampal mossy fiber synapses in schizophrenia: A postmortem morphometric study

  2005cites this paper
• Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis.

  2005cites this paper
• Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.

  2004cites this paper
• Effects of birth insult and stress at adulthood on excitatory amino acid receptors in adult rat brain

  2004cites this paper
• NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia.

  2004cites this paper
• Long‐term effects of amygdala GABA receptor blockade on specific subpopulations of hippocampal interneurons

  2004cites this paper
• The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications

  2004cites this paper
• Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals

  2004cites this paper
• Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics

  2004cites this paper
• Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium

  2004cites this paper
• Glutamate receptor genes as candidates for schizophrenia susceptibility

  2003cites this paper
• Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.

  2003cites this paper
• Glutamate Receptors and Transporters in the Hippocampus in Schizophrenia

  2003cites this paper
• Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder.

  2003cites this paper
• Defining the Role of Specific Limbic Circuitry in the Pathophysiology of Schizophrenia and Bipolar Disorder

  2002cites this paper
• An RT-PCR study of 5-HT(6) and 5-HT(7) receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia.

  2002cites this paper
• Stress and the progression of the developmental hypothesis of schizophrenia.

  2002cites this paper
• EVIDENCE FOR ACOMMON NEUROPATHOLOGY IN MAJORDEPRESSION, BIPOLARDISORDER AND SCHIZOPHRENIA

  2002cites this paper